http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105164138-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4eb6dbca25e5f9459a6c5f592728c787
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-14
filingDate 2014-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c09c7cb01e9e27886e850a68b6968041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4c81d4854a91dda8b82e2755f71f3d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9779879646a0e5c979679ffb7974189e
publicationDate 2015-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105164138-A
titleOfInvention Neomorpholino anthracycline derivatives
abstract The present invention relates to novel morpholinyl anthracycline derivatives having cytotoxic activity and useful in the treatment of diseases such as cancer, cell proliferative diseases and viral infections. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising them and methods of treating diseases using such compounds or pharmaceutical compositions comprising them.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107001384-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115043895-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110776501-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108864221-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108864221-A
priorityDate 2013-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012073217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102159248-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2247885-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9010639-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2296495-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9802446-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467125010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467390341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467146229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467390381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466067297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467390342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465078431

Total number of triples: 48.